U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07452354) titled 'AI-Based Diabetic Foot Recurrence Cohort' on Feb. 28.
Brief Summary: Diabetic foot ulcer (DFU) is a major adverse outcome of diabetes, which itself is one of the most significant chronic diseases. The recurrence of DFU involves multiple risk factors, including altered foot loading patterns, patient compliance, family care capacity, blood glucose monitoring, degree of ischemia, and systemic disease control. Early identification of recurrence signs and timely follow-up interventions are crucial for improving prognosis, reducing disability rates, and lowering healthcare costs. However, traditional follow-up systems lack individualized ...